Literature DB >> 27502128

[Standardize the endovascular treatment for arteriosclerosis obliterans].

S M Wang1, C Yao.   

Abstract

Endovascular therapy has become the first-line strategy for most peripheral artery disease cases. Currently, many guidelines recommend endovascular therapy as the first choice for arteriosclerosis obliterans. Recently, drug-eluting stent and drug-coated balloon are available. The clinical outcomes have been greatly improved with the evolution of devices. However, the long-term outcomes of endovascular therapy for arteriosclerosis obliterans are still not satisfied. Many centers treat arteriosclerosis obliterans using endovascular therapy in appropriately. In this editorial, an evidence-based approach and some strategies will be discussed to standardize the endovascular treatment and improve the result of endovascular therapy for arteriosclerosis obliterans.

Entities:  

Mesh:

Year:  2016        PMID: 27502128     DOI: 10.3760/cma.j.issn.0529-5815.2016.08.002

Source DB:  PubMed          Journal:  Zhonghua Wai Ke Za Zhi        ISSN: 0529-5815


  3 in total

1.  Protective effect of rivaroxaban on arteriosclerosis obliterans in rats through modulation of the toll-like receptor 4/NF-κB signaling pathway.

Authors:  Xinjiang Lou; Zhi Yu; Xiaoxia Yang; Jie Chen
Journal:  Exp Ther Med       Date:  2019-07-03       Impact factor: 2.447

2.  Clinical Efficacy of Interventional Therapy on Lower Extremity Arteriosclerosis Obliterans and Prognostic Factors.

Authors:  Deshuang Xiao; Jun Song
Journal:  Comput Math Methods Med       Date:  2022-08-04       Impact factor: 2.809

3.  Effects of Drug-Coated Balloon Therapy on CT Imaging Results and Levels of Vascular Inflammatory Cytokines in Patients with Arteriosclerosis Obliterans Lesions.

Authors:  Yanlin Yang
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-22       Impact factor: 2.650

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.